Syaiful Choiri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Syaiful Choiri has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
- Ahmad Ainurofiq
Pharmaceutical Technology and Drug Delivery, Department of Pharmacy, Universitas Sebelas Maret, Surakarta, Indonesia, 57126
12 shared publications Ilham Kuncahyo
4 shared publicationsAbdul Rohman
Department of Pharmaceutical Chemistry, Universitas Gadjah Mada, Yogyakarta, Indonesia
3 shared publications- Abdul Rohman
Gadjah Mada University
3 shared publications Achmad Fudholi
Department of Pharmaceutics, Universitas Gadjah Mada, Yogyakarta, Indonesia
3 shared publicationsAhmad Ainurofiq
Pharmaceutical Technology and Drug Delivery, Department of Pharmacy, Universitas Sebelas Maret, Surakarta, Indonesia
3 shared publications
Latest Publications
- Open Access
- 15 September 2026
- Published by Elsevier in Next Materials
- Vol. 13
Design, characterisation, and phase transformation of a tranexamic acid–gallic acid cocrystal
- 15 September 2026
- Published by Elsevier in Next Materials
- Vol. 13
Open AccessDesign, characterisation, and phase transformation of a tranexamic acid–gallic acid cocrystal
- 11 August 2026
- Published by Springer Nature in BioNanoScience
- Vol. 16  (8) , 533
Self-nanoemulsion Containing Synergistic Polyherbal Combinations: DoE-based Formulation Development and Pharmacokinetics Study
- 11 August 2026
- Published by Springer Nature in BioNanoScience
- Vol. 16  (8) , 533
Self-nanoemulsion Containing Synergistic Polyherbal Combinations: DoE-based Formulation Development and Pharmacokinetics Study
- 22 January 2026
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 691, 126617
Hyaluronic/Poloxamers-co-decorated nanoemulsion containing naringenin and quercetin for psoriasis treatment
- 22 January 2026
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 691, 126617
Hyaluronic/Poloxamers-co-decorated nanoemulsion containing naringenin and quercetin for psoriasis treatment
- Open Access
- 2 October 2025
- Published by Etflin in Sciences of Pharmacy
- Vol. 4  (4) , 261-269
The Effect of Poloxamer 188 on the Solubility and Dissolution Behaviors of Piroxicam-PEG 4000 Solid Dispersions
Piroxicam (PRX), a non-steroidal anti-inflammatory drug (NSAID), is classified as a biopharmaceutical classification system class II (high permeability and low solubility), which limits its bioavailability. Enhancement of the dissolution rate is a key strategy to enhance the absorption. Solid dispersion systems, particularly when combined with amphiphilic multiple co-block polymers, offer a promising approach to address this challenge. This study aimed to investigate the effect of Poloxamer 188 (P188) and the solid dispersion technique on the solubility and dissolution rate of PRX. Polyethylene glycol (PEG) 4000-based solid dispersions containing PRX were prepared using varying concentrations of Poloxamer 188 surfactant through the fusion method. The solid dispersions were evaluated for saturated solubility in water for 24 hours. Selected formulations were further characterized using thermal analysis and vibrational spectroscopy. The optimized solid dispersion formulation was filled into capsules, and a dissolution assay was carried out to compare its performance with that of pure PRX capsules. The optimized formula, comprising 3% P188 and PEG4000, demonstrated a significant enhancement in saturation solubility parameters (p < 0.05), specifically the Cmax/S0 ratio. Additionally, dissolution testing showed a 22.22% increase in the dissolution rate of the PRX solid dispersion capsules compared to pure PRX capsules. In conclusion, P188-based solid dispersion containing PRX enhanced the solubility and dissolution rate, potentially improving therapeutic efficacy.
- 2 October 2025
- Published by Etflin in Sciences of Pharmacy
- Vol. 4  (4) , 261-269
Open AccessThe Effect of Poloxamer 188 on the Solubility and Dissolution Behaviors of Piroxicam-PEG 4000 Solid Dispersions
Piroxicam (PRX), a non-steroidal anti-inflammatory drug (NSAID), is classified as a biopharmaceutical classification system class II (high permeability and low solubility), which limits its bioavailability. Enhancement of the dissolution rate is a key strategy to enhance the absorption. Solid dispersion systems, particularly when combined with amphiphilic multiple co-block polymers, offer a promising approach to address this challenge. This study aimed to investigate the effect of Poloxamer 188 (P188) and the solid dispersion technique on the solubility and dissolution rate of PRX. Polyethylene glycol (PEG) 4000-based solid dispersions containing PRX were prepared using varying concentrations of Poloxamer 188 surfactant through the fusion method. The solid dispersions were evaluated for saturated solubility in water for 24 hours. Selected formulations were further characterized using thermal analysis and vibrational spectroscopy. The optimized solid dispersion formulation was filled into capsules, and a dissolution assay was carried out to compare its performance with that of pure PRX capsules. The optimized formula, comprising 3% P188 and PEG4000, demonstrated a significant enhancement in saturation solubility parameters (p < 0.05), specifically the Cmax/S0 ratio. Additionally, dissolution testing showed a 22.22% increase in the dissolution rate of the PRX solid dispersion capsules compared to pure PRX capsules. In conclusion, P188-based solid dispersion containing PRX enhanced the solubility and dissolution rate, potentially improving therapeutic efficacy.
- Open Access
- 23 June 2025
- Published by Universitas Gadjah Mada in Indonesian Journal of Pharmacy
- p. 225-235
Metformin HCl Controlled-Release Microparticles: DoE-Based Formulation Development and In-Vivo Proof of Concept Study
Conventional drug delivery systems deal with side effects caused by fluctuating plasma levels. However, controlled drug delivery systems face another challenge since big dosing results in voluminous dosage forms. The drug delivery system is only suitable for some patients. A sustained-release drug delivery system in microparticles is proposed to conquer the problems. This research proposed to develop and optimize sustained-release microparticles consisting of metformin HCl as a drug model and a mixture of Eudragit RS and Kollidon SR as a polymeric matrix using a Box-Behnken design. The evaluation was conducted regarding drug loading, entrapment efficiency, and particle size to determine the optimal formulation. Metformin HCl concentration and drug-polymer ratio were dominant increased particle size, drug loading, entrapment efficiency, and particle size distribution. Particle size testing showed that the optimized formulation had a microparticle size of 1.363 ± 0.03 µm with a particle size distribution of 1.131 ± 0.028. In vitro evaluation showed that the release of metformin HCl microparticles followed Weibull kinetics within 24 hours. In contrast, in vivo evaluation confirmed the ability of microparticles to control blood glucose levels in mice for up to 24 hours with a 59% reduction. The microparticle effectively controlled drug release and reduced blood glucose levels in the rats.
- 23 June 2025
- Published by Universitas Gadjah Mada in Indonesian Journal of Pharmacy
- p. 225-235
Open AccessMetformin HCl Controlled-Release Microparticles: DoE-Based Formulation Development and In-Vivo Proof of Concept Study
Conventional drug delivery systems deal with side effects caused by fluctuating plasma levels. However, controlled drug delivery systems face another challenge since big dosing results in voluminous dosage forms. The drug delivery system is only suitable for some patients. A sustained-release drug delivery system in microparticles is proposed to conquer the problems. This research proposed to develop and optimize sustained-release microparticles consisting of metformin HCl as a drug model and a mixture of Eudragit RS and Kollidon SR as a polymeric matrix using a Box-Behnken design. The evaluation was conducted regarding drug loading, entrapment efficiency, and particle size to determine the optimal formulation. Metformin HCl concentration and drug-polymer ratio were dominant increased particle size, drug loading, entrapment efficiency, and particle size distribution. Particle size testing showed that the optimized formulation had a microparticle size of 1.363 ± 0.03 µm with a particle size distribution of 1.131 ± 0.028. In vitro evaluation showed that the release of metformin HCl microparticles followed Weibull kinetics within 24 hours. In contrast, in vivo evaluation confirmed the ability of microparticles to control blood glucose levels in mice for up to 24 hours with a 59% reduction. The microparticle effectively controlled drug release and reduced blood glucose levels in the rats.
- Open Access
- 7 February 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10  (6) , 5668-5685
Doxycycline-Loaded pH-Sensitive Microparticles as a Potential Site-Specific Drug Delivery System against Periodontitis
A significant obstacle to the healing process of periodontitis is the development of bacterial biofilms within the periodontal pockets. The efficacy of bacterial biofilm therapy is often hindered by the inadequate penetration of antibacterial agents and the nonspecific targeting of bacteria. This study proposes a novel strategy involving the utilization of pH-sensitive microparticles (MPs) of doxycycline (DOX) to enhance biofilm penetration and enable targeted delivery of DOX to infection sites associated with periodontitis. The MPs were developed using a double-emulsion technique with poly(d,l-lactide-co-glycolide) and chitosan in a 1:1 ratio. The morphology of DOX-MP exhibits a spherical form with a particle size of 3.54 ± 0.32 μm and a PDI of 0.221 ± 0.02. The DOX-MP also had great encapsulation efficiency (69.43% ± 5.32) and drug loading efficiency (14.81% ± 1.32) with regulated drug release kinetics and accelerated release rates under low-pH conditions. The antimicrobial activity was evaluated against Escherichia coli and Staphylococcus aureus, and the results indicated the absence of any viable bacterial colonies after 18 h at twice the minimum inhibitory concentration value. Hydrogel-based MPs deliver DOX to the periodontal pocket infection site for ease of use. In situ hydrogels used Pluronic F127 and F68 as the main polymer composition and hydroxypropyl methylcellulose as the adhesion polymer. This formulation exhibited a liquid state at room temperature (25 °C) but went through gelation at 36 °C. The formulation also had good mucoadhesive characteristics (42.65 ± 3.53 dyn/cm2) and good drug permeation at acidic pH in Mueller-Hinton Broth media with the addition of E. coli and S. aureus bacteria. Ex vivo antibacterial activity significantly reduced the microbial count, biofilm quantity, and metabolic activity, confirming the desired antibacterial effect. Hence, the utilization of free drugs and DOX-MPs did not exhibit a notable dissimilarity, showing that integrating the drug into the matrix was not hindering its antibacterial efficacy.
- 7 February 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10  (6) , 5668-5685
Open AccessDoxycycline-Loaded pH-Sensitive Microparticles as a Potential Site-Specific Drug Delivery System against Periodontitis
A significant obstacle to the healing process of periodontitis is the development of bacterial biofilms within the periodontal pockets. The efficacy of bacterial biofilm therapy is often hindered by the inadequate penetration of antibacterial agents and the nonspecific targeting of bacteria. This study proposes a novel strategy involving the utilization of pH-sensitive microparticles (MPs) of doxycycline (DOX) to enhance biofilm penetration and enable targeted delivery of DOX to infection sites associated with periodontitis. The MPs were developed using a double-emulsion technique with poly(d,l-lactide-co-glycolide) and chitosan in a 1:1 ratio. The morphology of DOX-MP exhibits a spherical form with a particle size of 3.54 ± 0.32 μm and a PDI of 0.221 ± 0.02. The DOX-MP also had great encapsulation efficiency (69.43% ± 5.32) and drug loading efficiency (14.81% ± 1.32) with regulated drug release kinetics and accelerated release rates under low-pH conditions. The antimicrobial activity was evaluated against Escherichia coli and Staphylococcus aureus, and the results indicated the absence of any viable bacterial colonies after 18 h at twice the minimum inhibitory concentration value. Hydrogel-based MPs deliver DOX to the periodontal pocket infection site for ease of use. In situ hydrogels used Pluronic F127 and F68 as the main polymer composition and hydroxypropyl methylcellulose as the adhesion polymer. This formulation exhibited a liquid state at room temperature (25 °C) but went through gelation at 36 °C. The formulation also had good mucoadhesive characteristics (42.65 ± 3.53 dyn/cm2) and good drug permeation at acidic pH in Mueller-Hinton Broth media with the addition of E. coli and S. aureus bacteria. Ex vivo antibacterial activity significantly reduced the microbial count, biofilm quantity, and metabolic activity, confirming the desired antibacterial effect. Hence, the utilization of free drugs and DOX-MPs did not exhibit a notable dissimilarity, showing that integrating the drug into the matrix was not hindering its antibacterial efficacy.
- Open Access
- 11 December 2024
- Published by Universitas Gadjah Mada in Majalah Obat Tradisional
- Vol. 29  (3) , 357-365
In vivo Wound Healing Activity of Tamanu Oil (Calophyllum inophyllum l.) Extracted by Cold-Pressed and Hot-Pressed Methods and Their Fatty Acids Composition
Tamanu oil is a promising natural wound healer due to its chemical compounds, particularly fatty acids. Cold-pressed or hot-pressed methods are commonly used to obtain this oil from Calophyllum seed. However, there needs to be research documenting the impact of these two extraction methods on the fatty acid profile and wound healing activity. Therefore, the study aims to characterize the fatty acid profiles of cold-pressed and hot-pressed tamanu oils using Gas Chromatography and evaluate their wound healing activity in vivo. The fatty acid profiles were analyzed using GC, and the wound healing tests were conducted on animal subjects divided into four groups: negative control, positive control (Bioplacenton®), cold-pressed tamanu oil, and hot-pressed tamanu oil. Cold-pressed tamanu oil showed superior fatty acid characteristics with an acid value of 38,71 Mg KOH/g fat and a peroxide value of 3,0095 mEq O2/kg, indicating that oil is stable against oxidation. The length of the wound was observed daily for up to 8 days to assess its effect. The parameters observed were the percentage of wound healing and the total AUC based on the average length of the wound. Cold-pressed tamanu oil demonstrated the highest wound healing efficacy compared to both the positive control and hot-pressed tamanu oils. Both cold (11,67± 0,78) and hot-pressed tamanu oil (11,87 ± 0,61) exhibited significant differences in AUC value compared to the negative control group (13,07 ± 0,38), highlighting the potential of tamanu oil as a wound healing agent.
- 11 December 2024
- Published by Universitas Gadjah Mada in Majalah Obat Tradisional
- Vol. 29  (3) , 357-365
Open AccessIn vivo Wound Healing Activity of Tamanu Oil (Calophyllum inophyllum l.) Extracted by Cold-Pressed and Hot-Pressed Methods and Their Fatty Acids Composition
Tamanu oil is a promising natural wound healer due to its chemical compounds, particularly fatty acids. Cold-pressed or hot-pressed methods are commonly used to obtain this oil from Calophyllum seed. However, there needs to be research documenting the impact of these two extraction methods on the fatty acid profile and wound healing activity. Therefore, the study aims to characterize the fatty acid profiles of cold-pressed and hot-pressed tamanu oils using Gas Chromatography and evaluate their wound healing activity in vivo. The fatty acid profiles were analyzed using GC, and the wound healing tests were conducted on animal subjects divided into four groups: negative control, positive control (Bioplacenton®), cold-pressed tamanu oil, and hot-pressed tamanu oil. Cold-pressed tamanu oil showed superior fatty acid characteristics with an acid value of 38,71 Mg KOH/g fat and a peroxide value of 3,0095 mEq O2/kg, indicating that oil is stable against oxidation. The length of the wound was observed daily for up to 8 days to assess its effect. The parameters observed were the percentage of wound healing and the total AUC based on the average length of the wound. Cold-pressed tamanu oil demonstrated the highest wound healing efficacy compared to both the positive control and hot-pressed tamanu oils. Both cold (11,67± 0,78) and hot-pressed tamanu oil (11,87 ± 0,61) exhibited significant differences in AUC value compared to the negative control group (13,07 ± 0,38), highlighting the potential of tamanu oil as a wound healing agent.
- 10 July 2024
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 661, 124459
QbD-based formulation development of resveratrol nanocrystal incorporated into soluble mesoporous material: Pharmacokinetic proof of concept study
- 10 July 2024
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 661, 124459
QbD-based formulation development of resveratrol nanocrystal incorporated into soluble mesoporous material: Pharmacokinetic proof of concept study
- Open Access
- 11 December 2023
- Published by Maad Rayan Publishing Company in Pharmaceutical Sciences
- Vol. 30  (1) , 98-108
Phyto-nanoemulsion Containing Tea Leaves Extract Incorporated into A Hydrogel-based Peel-off Mask Formulation: Development, Antioxidant Assay, and Ex-vivo Transport Study
Background: Tea leaves contain remarkable antioxidant compounds suitable for cosmetics formulation development targeting anti-aging purposes. However, due to its hydrophilicity, it faced the main hurdle, namely the permeation of the potential antioxidant compounds. Nanoemulsion formulation offers the permeation improvement of water-soluble compounds Therefore, this work purposed to formulate and develop the nanoemulsion formulation containing tea leaf extract incorporated into a peel-off mask formulation and an ex-vivo transport study. Methods: The nanoemulsion formulation was developed according to self-nano emulsification. The optimization process was performed using a design of experiment to define optimized formulation based on quality target product profiles. Dried green tea leaf extract (DGTE) was obtained by lyophilizing the boiled water-based extract. Antioxidant and phenolic content assays were also evaluated. The optimized formulation was incorporated into a hydrogel-based peel-off mask formulation. Permeated polyphenol through a rat skin membrane was carried out along with deposited polyphenols in the skin membrane. Results: The results indicated that DGTE had powerful antioxidants with IC50 less than 15 mg/mL. The optimized nanoemulsion comprised 21.62% virgin coconut oil, 48.38% Tween 80, and 30% PEG 400, producing a droplet size of less than 50 nm. The peel-off formulation was successfully formulated along with PVA 10-11% and HPMC 0.25-1% with a drying time of around 30 min. The nanoemulgel peel-off mask formulation played significant roles in enhancing the permeation and deposition in the percutaneous transport using rat skin membrane for roughly 200% and 50%, respectively. Conclusion: The nanoemulsion incorporated into a hydrogel-based peel-off mask enhanced the permeation of DGTE polyphenol compounds.
- 11 December 2023
- Published by Maad Rayan Publishing Company in Pharmaceutical Sciences
- Vol. 30  (1) , 98-108
Open AccessPhyto-nanoemulsion Containing Tea Leaves Extract Incorporated into A Hydrogel-based Peel-off Mask Formulation: Development, Antioxidant Assay, and Ex-vivo Transport Study
Background: Tea leaves contain remarkable antioxidant compounds suitable for cosmetics formulation development targeting anti-aging purposes. However, due to its hydrophilicity, it faced the main hurdle, namely the permeation of the potential antioxidant compounds. Nanoemulsion formulation offers the permeation improvement of water-soluble compounds Therefore, this work purposed to formulate and develop the nanoemulsion formulation containing tea leaf extract incorporated into a peel-off mask formulation and an ex-vivo transport study. Methods: The nanoemulsion formulation was developed according to self-nano emulsification. The optimization process was performed using a design of experiment to define optimized formulation based on quality target product profiles. Dried green tea leaf extract (DGTE) was obtained by lyophilizing the boiled water-based extract. Antioxidant and phenolic content assays were also evaluated. The optimized formulation was incorporated into a hydrogel-based peel-off mask formulation. Permeated polyphenol through a rat skin membrane was carried out along with deposited polyphenols in the skin membrane. Results: The results indicated that DGTE had powerful antioxidants with IC50 less than 15 mg/mL. The optimized nanoemulsion comprised 21.62% virgin coconut oil, 48.38% Tween 80, and 30% PEG 400, producing a droplet size of less than 50 nm. The peel-off formulation was successfully formulated along with PVA 10-11% and HPMC 0.25-1% with a drying time of around 30 min. The nanoemulgel peel-off mask formulation played significant roles in enhancing the permeation and deposition in the percutaneous transport using rat skin membrane for roughly 200% and 50%, respectively. Conclusion: The nanoemulsion incorporated into a hydrogel-based peel-off mask enhanced the permeation of DGTE polyphenol compounds.
- Open Access
- 2 October 2023
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 8  (41) , 38676-38689
Rational Design and Development of a Soluble Mesoporous Carrier for the Solidification of a Preconcentrated Self-Nanoemulsion Formulation
The solidification of self-preconcentrated nanoemulsion without changes in nanodroplet formation gains particular consideration due to the interaction between solidified carriers. This work aimed to develop mannitol mesoporous as a soluble carrier for supersaturated self-nanoemulsion (SSNE) using a design of experiment (DoE) approach. The mesoporous carrier was prepared by a spray-drying technique. The type of templating agent (TA) used to form a porous system, the amount of TA, and solid loading in the spray-drying process were studied. Several characterizations were performed for mannitol mesoporous formation, namely, powder X-ray diffraction, thermal analysis, scanning electron microscopy, and surface area analyzer. Solidification of SSNE incorporated into the mesoporous mannitol was carried out, followed by compaction behavior, flowability, and nanodroplet formation. The results revealed several process parameters for preparing the mesoporous mannitol, notably TA, which gained more significant consideration. Solid loading in the mesoporous preparation system reduced the surface area and pore size and did not affect solid SSNE flowability. The amount of TA increased the pore size and volume dramatically as well as the compactibility and flowability. Ammonium carbonate was the preferable TA for preparing the mesoporous carrier, particularly for the nanodroplet formulation process. In addition, synergistic and antagonistic interactions between factors were also observed. The optimized mesoporous carrier was applied for solidification, and there was no difference between SSNE and solid SSNE in the performance of nanodroplet formation.
- 2 October 2023
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 8  (41) , 38676-38689
Open AccessRational Design and Development of a Soluble Mesoporous Carrier for the Solidification of a Preconcentrated Self-Nanoemulsion Formulation
The solidification of self-preconcentrated nanoemulsion without changes in nanodroplet formation gains particular consideration due to the interaction between solidified carriers. This work aimed to develop mannitol mesoporous as a soluble carrier for supersaturated self-nanoemulsion (SSNE) using a design of experiment (DoE) approach. The mesoporous carrier was prepared by a spray-drying technique. The type of templating agent (TA) used to form a porous system, the amount of TA, and solid loading in the spray-drying process were studied. Several characterizations were performed for mannitol mesoporous formation, namely, powder X-ray diffraction, thermal analysis, scanning electron microscopy, and surface area analyzer. Solidification of SSNE incorporated into the mesoporous mannitol was carried out, followed by compaction behavior, flowability, and nanodroplet formation. The results revealed several process parameters for preparing the mesoporous mannitol, notably TA, which gained more significant consideration. Solid loading in the mesoporous preparation system reduced the surface area and pore size and did not affect solid SSNE flowability. The amount of TA increased the pore size and volume dramatically as well as the compactibility and flowability. Ammonium carbonate was the preferable TA for preparing the mesoporous carrier, particularly for the nanodroplet formulation process. In addition, synergistic and antagonistic interactions between factors were also observed. The optimized mesoporous carrier was applied for solidification, and there was no difference between SSNE and solid SSNE in the performance of nanodroplet formation.